|
⚲
|
| Keyboard |
| Deep Track Capital LP | |
|---|---|
| Firm | |
| Address | 200 Greenwich Avenue Greenwich, CT 06830 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Deep Track Biotechnology Offshore Fund Ltd | 021-394242 | Promoter | 1,498.9 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dynavax Technologies Corp DVAX
Common Stock, par value $0.001 per share
|
2026-02-10 | Tender | 15,726,349 | ||
|
LB Pharmaceuticals Inc LBRX
Pre-Funded Warrants (Right to Buy) · derivative
|
2026-02-06 | Buy | 93,925 | $21.17 | 1,988,392 |
|
LB Pharmaceuticals Inc LBRX
Pre-Funded Warrants (Right to Buy) · derivative
|
2026-02-06 | Buy | 378,444 | $21.17 | 8,011,659 |
|
Nektar Therapeutics NKTR
Common Stock
|
2024-05-10 | Sell | 56,000 | $1.78 | 99,680 |